Brent Tetri
Physician · SLUcare Physician Group
Credentials: · · · ·
History
- 2022–Present
1979–1983- 1975–1979
Research
Mechanisms of NAFLD development and therapeutic strategies
Review · Nature Medicine · 2018 · 3,515 citations
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
The American Journal of Gastroenterology · 1999 · 3,242 citations
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
New England Journal of Medicine · 2010 · 2,636 citations
60 papers
58 papers
36 papers
34 papers
34 papers
33 papers
- JT
30 papers · 16 as a resident
21 papers
Grants
- 2002–2027
The Saint Louis University Component of the NASH Clinical Research Network
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $12M · Saint Louis University
- 2004–2008
Molecular Mechanisms of Pancreatic Fibrogenesis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1M · Saint Louis University
- 1995–2001
Transcriptional Control of Inflammation in Pancreatitis
National Institute of Diabetes and Digestive and Kidney Diseases · R29
Contact PI · $560K · Saint Louis University
- 1989
The Function of Glutathione in Hepatic Inflammation
National Institute of Diabetes and Digestive and Kidney Diseases · F32
Contact PI · $31.8K · University of California, San Francisco
Clinical trials
- 2025–2027
Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis
Principal investigator · Not yet recruiting
Keith Pereira, MD:
- 2020–2025
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Principal investigator · Completed
Johns Hopkins Bloomberg School of Public Health
- 2013–2015
Principal investigator · Completed · Phase 1
Galectin Therapeutics Inc.
- 2003–2006
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
Principal investigator · Completed · Phase 4
St. Louis University